Up Food And Drug Administration

• 

  FDA Approves HPV Vaccine For People Up To 45

  Most sexually active individuals in the United States will become infected by HPV sometime in their lifetimes.

• 

  Bacteria In Chewable Tobacco May Up Risk Of Cancer

  Are you addicted to smokeless tobacco products like plain chewable tobacco leaves, khaini, pan masala, zarda and gutka? Be warned, as researchers have identified several species of bacteria in these products that can increase the risk of cancer, lung infections, diarrhoea and vomiting.

• 

  FDA Warns Former Sun Pharma US Drug Factory Over Quality Concerns

  The US Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.

• 

  Mother Dairy Denies Detergent in Milk, Sends Sample for Retest

  Mother Dairy today denied allegations that detergent was found in one of the samples of milk picked up from its collection centres, saying it has sent it for retesting in a lab in Kolkata.

• 

  Detergent Found in Milk Sample, Says UP Food Administration

  The UP Food and Drug Administration said on Tuesday that it has found detergent in one of the samples of milk picked from Mother Dairy's collection centres, a claim contested by the Delhi-based company.

• 

  Maggi Noodles Row: Uttar Pradesh Food Administration Gives Nod to Prosecute Nestle

  The Uttar Pradesh Food Safety and Drug Administration has given its go ahead to prosecute Nestle India, which manufactures instant noodles Maggi, a batch of which was found to contain dangerous levels of lead.

• Why Dishman Pharma is Up 90% in a Year

  Dishman primarily provides outsourcing services for Active Pharmaceutical Ingredients (API) to large pharma companies and help them in commercialisation of those products.

• Indian Drug Makers to Pay Higher Facility Fees on US Hike

  Drug makers from India, the biggest source of medicines to the US, may soon have to cough up 12-15 per cent more in annual facility fees as the Food and Drug Administration (FDA) has announced new rates.

• 

  Ranbaxy up; Nod to Generic Version of Novartis Drug

  Ranbaxy Laboratories rose 5.8 per cent in early trading after the US Food and Drug Administration (FDA) on Thursday said it has approved the company's generic version of Novartis AG's blood pressure drug Diovan.

• US regulator pulls up Smruthi Organics for norms violation in unit

  In a filing to the BSE, the company said European Directorate for Quality of Medicines (EDQM) and the US Food and Drug Administration (USFDA) have inspected its active pharmaceutical ingredients site from October 14-18, 2013.

• Taking steps to firm up manufacturing processes: Wockhardt

  Lapses at operative as well as supervisory levels at Wockhardts plant in Waluj resulted in action by the Food and Drug Administration (FDA) but the company has taken a number of steps including hiring of international consultants to rectify the issues, the drug major has said.

• Indian drug makers face higher costs for sale in US

  Many Indian drug makers will soon have to bear higher costs for sale of products in American markets, as the US Food and Drug Administration (FDA) is hiking the fees for generic drug makers by up to 48 per cent from October.

• FDA alert affects potential sales of $100 million: Wockhardt

  Drug maker Wockhardt Ltd said up to $100 million in annualised revenue could be lost as a result of a US Food and Drug Administration "import alert" on one of its plants, but said it should be able to restore most of that within 6 to 9 months by shifting production elsewhere.

• Herbal oil ads: Govinda tells FDA he was unaware of laws

  Last month, the Food and Drug Administration (FDA) had filed 67 complaints at police stations across the state under various sections of the Drugs and Magic Remedies (Objectionable advertisements) Act, 1955. These include complaints against advertisements of products such as 'Sandhi Sudha plus', 'Step up herbal oil' and 'Power Prash', which are pro...

• Panacea to scale up anti-cancer production, starts new plant

  Drug firm Panacea Biotec said it is scaling up production of anti-cancer products with the commissioning of its new facility at Baddi in Himachal Pradesh set up at an investment of Rs 55 crore.